Injectable Influenza Vaccine
Awarded Award Notice Posted
- Solicitation number
- SPE2DP21D0006
- Agency
- Medical Supply Chain Troop Support, Department of Defense
- Awarded
- to Glaxosmithkline, LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- SPE2DP21D0006 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- USA
Notice details come from SAM.gov. Updated .
About this opportunity
On February 23, 2021, the Defense Logistics Agency Troop Support Medical awarded contract SPE2DP21D0006 to GlaxoSmithKline LLC under solicitation SPE2DP-21-R-0120. The contract award, valued at $29,667,200, is for the delivery of injectable influenza vaccine to support the agency's 2021/2022 influenza vaccine contract requirements. Clinical Item Numbers 0002, 0004, and 0005 were awarded for an estimated quantity of injectable influenza vaccines.
Notice text
On February 23, 2021, CLINS 0002, 0004, & 0005 of solicitation SPE2DP-21-R-0120 were awarded to GlaxoSmithKline LLC for the 2021/2022 Injectable Influenza Vaccine Contract (SPE2DP21D0006).
Awarded contract SPE2DP21D0006 to GLAXOSMITHKLINE LLC for 29667200.00 on 2021-02-23.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Injectable Influenza Vaccine | Award Notice | |
| Injectable Influenza Vaccine | Award Notice | |
| Injectable Influenza Vaccine | Solicitation | |
| Injectable Influenza Vaccine | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity